Cargando…
The clinical utility of genetic testing in breast cancer kindreds: a prospective study in families without a demonstrable BRCA mutation
We report prospectively observed risk for breast cancer in breast cancer kindreds without a demonstrable BRCA1/2 mutation. According to family history, the optimal available member(s) of each breast cancer kindred attending our clinic was tested for BRCA mutations. Women in families without a demons...
Autores principales: | Møller, Pål, Stormorken, Astrid, Holmen, Marit Muri, Hagen, Anne Irene, Vabø, Anita, Mæhle, Lovise |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3962741/ https://www.ncbi.nlm.nih.gov/pubmed/24619173 http://dx.doi.org/10.1007/s10549-014-2902-1 |
Ejemplares similares
-
High penetrances of BRCA1 and BRCA2 mutations confirmed in a prospective series
por: Møller, Pål, et al.
Publicado: (2010) -
Survival in Norwegian BRCA1 mutation carriers with breast cancer
por: Hagen, Anne Irene, et al.
Publicado: (2009) -
Genetic variants of prospectively demonstrated phenocopies in BRCA1/2 kindreds
por: Dominguez-Valentin, Mev, et al.
Publicado: (2018) -
No Sib Pair Concordance for Breast or Ovarian Cancer in BRCA1 Mutation Carriers
por: Møller, Pål, et al.
Publicado: (2007) -
Ten modifiers of BRCA1 penetrance validated in a Norwegian series
por: Heramb, Cecilie, et al.
Publicado: (2015)